DMY Squared Competitors
| DMYY Stock | 13.45 0.45 3.46% |
Pair Correlation for DMY Squared and ESH Acquisition Overview
Weak diversification
For the present investment horizon, the measured correlation between DMYY and ESHA stands at 0.31, or Weak diversification. The overlap area represents the portion of risk that may be diversified away when both instruments are held together and nothing else in the portfolio changes.
Moving together with DMY Stock
Moving against DMY Stock
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DMY Squared's price to converge to an average value over time is called mean reversion.
DMY Squared Competition Correlation Matrix
Reviewing how dMY Squared Technology moves relative to competing stocks can show whether peer exposure is reducing portfolio risk or simply repeating the same market bet. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DMY Stock performing well and DMY Squared Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DMY Squared's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TDAC | 0.07 | 0.01 | 0.43 | 0.15 | 0.00 | 0.19 | 0.95 | |||
| FORL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FTII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| WLACW | 3.87 | -0.30 | 0.00 | 0.25 | 0.00 | 9.76 | 28.02 | |||
| TBMC | 3.47 | -0.06 | 0.00 | -0.16 | 0.00 | 9.54 | 40.51 | |||
| BKHA | 0.29 | 0.04 | 0.00 | 6.55 | 0.00 | 0.97 | 6.36 | |||
| HSPO | 1.93 | 0.25 | 0.04 | 0.08 | 3.37 | 2.46 | 61.25 | |||
| WINV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ESHA | 2.35 | 0.03 | 0.06 | -0.12 | 4.03 | 5.07 | 53.87 |
Peer Comparison: Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in dMY Squared Technology financial statement analysis. It represents the amount of money remaining after all of dMY Squared Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Compare dMY Squared Technology and related stocks such as Translational Development, Four Leaf Acquisition, and Futuretech II Acquisition Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TDAC | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -70.7 K | -485.6 K | -71 K | -63.9 K | -67.1 K |
| FORL | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | -6.3 K | 834.8 K | 403.3 K | 463.8 K | 451.6 K |
| FTII | -438 | -438 | -438 | -438 | -438 | -438 | -438 | -438 | -438 | -438 | -438 | -438 | 700 K | 2.9 M | -747 K | -672.3 K | -638.7 K |
| WLACW | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 116.9 K | 3.4 M | 2 M |
| TBMC | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -1.2 K | -4 K | 1.3 M | 1.7 M | -8.3 M | -7.9 M |
| BKHA | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | -113 | 1.9 M | 1.3 M | 1.5 M | 1.2 M |
| HSPO | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | -124 K | 2.9 M | 2.7 M | 3.1 M | 2 M |
| ESHA | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -864 | -19.5 K | 1.9 M | 3.9 T | 4.5 T | 4.7 T |
DMY Squared Competitive Analysis
Within its peer group that includes Translational Development, Four Leaf, and Futuretech, DMY Squared stands out in several ways. The company commands a 52.5 M market valuation. DMY Squared posts a -188.70% return on equity, reflecting current earnings headwinds. On pure scale, Translational Development is the bigger entity with market caps of 231.1 M versus 52.5 M. Return on equity favors Four Leaf at 218.28%, well ahead of DMY Squared at -188.70%. On pure scale, DMY Squared is the larger business with market caps of 52.5 M versus 51.6 M.| Better Than Average | Worse Than Peers | View Performance Chart |
DMY Squared Competition Peer Performance Charts
How to Analyze DMY Squared Against Peers
DMY Squared's peer analysis compares DMY Squared with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:- Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
- Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
- Check valuation dispersion: Review whether DMY Squared trades at a premium or discount versus peers and why.
- Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
- Document the thesis: Record where DMY Squared leads or lags and what catalysts could close or widen the gap.
Peer Comparison Metrics & Methodology
Return on invested capital comparison for DMY Squared versus peers reveals which companies in the group are genuinely creating value. Momentum comparison for DMY Squared across peers can signal rotation when peers accelerate while DMY Squared lags or vice versa. Divergence between DMY Squared and its peers often has a fundamental explanation worth investigating. The data shown is informational and should not be interpreted as guidance. Relative comparison helps show where DMY Squared is stronger or weaker against peers. For peer comparison, DMY Squared has a market cap of 52.53 M.
Unless otherwise specified, data for dMY Squared Technology is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day.